New KMY tablet safety trial launches in healthy volunteers
Knowledge-focused
Not yet recruiting
This early-stage study tests the safety and tolerability of KMY tablets in 120 healthy adults aged 18 to 45. Participants receive either the drug or a placebo, and researchers monitor side effects, how the drug moves through the body, and whether food affects its absorption. The …
Phase: PHASE1 • Sponsor: Lei Yunshang Group • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC